Transparency Market Research (TMR) in a new market study reports that
the global vitreous tamponades market is highly fragmented with the
presence of small and medium sized players. A distinct feature of the
market is that each region is dominated by a select number of
players. For instance, the vitreous tamponades market in North
America is dominated by Novartis AG and Valeant Pharmaceuticals that
hold more than 50% of market share. Likewise, the European market for
vitreous tamponades is characterized by the dominance of Dutch
Ophthalmic Research Center B.V., AL. CHI. MI.A. srl, and Fluron
GmbH.
Request for Sample Copy of Report @
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=4233
A notable trend observed in the market is the thrust on research and
development by keen companies to introduce newer products. This is to
serve the demand for case - specific products for specialty medical
procedures.
As per estimates of the TR report, the global vitreous tamponades
market stood at a valuation of US$69.3 mn in 2016and is likely to
present an opportunity worth US$89.9 mn by the end of 2025 at a CAGR
of 3.0% for the forecast period between 2017 and 2025.
In terms of product, liquid tamponades emerged as the lucrative
segment holding 53.9% of the market in 2016. The supremacy of the
segment is due to the widespread use of liquid tamponades over
gaseous tamponades. The ophthalmology clinics send-use segment led
the global vitreous tamponades market vis-à-vis revenue in 2016.
Geography-wise, North America holds the leading share amongst other
regions in vitreous tamponades market.
Enquiry for discount on this report @
https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=4233
Rising Incidence of Diabetes Leading to Retinal Conditions Boosts
Growth
“Steady growth of vitreous tamponades market is witnessed due to
increasing incidence of retinal detachments, diabetic retinopathy,
macular pucker, and other retinal disorders,” explains the lead
author of the study. As per statistics of the American Academy of
Ophthalmology, 17 million cases of proliferative diabetic retinopathy
were recorded globally in 2013. Diabetic retinopathy exclusively
requires vitrectomy, which in turn, is stoking demand for vitreous
tamponades. This is because modern vitrectomy techniques rely heavily
on vitreous substitutes for the reattachment of the retina.
Moreover, as per statistics of the International Diabetes Federation,
around 300 million diabetes cases were reported in 2010 globally and
this figure is likely to reach 438 million by 2030. The rising
incidence of diabetes that has a high risk to cause diabetes
retinopathy and other retinal disorders is stoking the demand for
tamponades to prevent impaired vision and even blindness.
Prevalence of Retinal Detachment Stokes Demand for Tamponades for
Vitrectomy
Further, the rising incidence of retinal detachment and other
vitreoretinal disorders that can be corrected with vitrectomy is
positively influencing the vitreous tamponades market. Vitrectomy
involves surgical removal of the vitreous humor to be replaced with
synthetic substitutes known as vitreous tamponades. In the human eye,
vitreous humor is a vital component that acts as nutrition and as a
refractive medium. In the event of trauma or upon aging, the vitreous
humor disintegrates leading to tearing or detachment of the highly
fragile retina.
Request for the TOC of the Report @
https://www.transparencymarketresearch.com/report-toc/4233
Apart from this, growing elderly population globally is also
considered as one of the key factors boosting the growth of vitreous
tamponades market. This is because the aged population has a high
risk of retinal breaks that requires effective treatment.
About Us
Transparency Market Research is a next-generation market intelligence
provider, offering fact-based solutions to business leaders,
consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow,
evolve, and mature. Our real-time data collection methods along with
ability to track more than one million high growth niche products are
aligned with your aims. The detailed and proprietary statistical
models used by our analysts offer insights for making right decision
in the shortest span of time. For organizations that require specific
but comprehensive information we offer customized solutions through
adhoc reports. These requests are delivered with the perfect
combination of right sense of fact-oriented problem solving
methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems
with right methodology of research is the key to help enterprises
reach right decision.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email:
sales@transparencymarketresearch.com
Website:
https://www.transparencymarketresearch.com
